Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface

Journal of Clinical Investigation

Volumn 114, Issue 6, 2004, Pages 744-754

  Red Horse, Kristy ^a   Zhou, Yan ^a   Genbacev, Olga ^a   Prakobphol, Akraporn ^a   Foulk, Russell ^b   McMaster, Michael ^a   Fisher, Susan J ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Nevada Center for Reproductive Medicine   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PLACENTA BARRIER; CELL DIFFERENTIATION; CYTOTROPHOBLAST; FETUS MONITORING; FETUS OUTCOME; HUMAN; NIDATION; NONHUMAN; OXYGEN TENSION; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; REVIEW; TROPHOBLAST;

ANIMALS; CELL DIFFERENTIATION; EMBRYO IMPLANTATION; EMBRYONIC DEVELOPMENT; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; TROPHOBLASTS;

EID: 9644254252     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200422991     Document Type: Review

References (125)

1. Wu, L, et al. 2003. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature. 421:942-947.
2. Barker, D.J. 2004. Developmental origins of adult health and disease. J. Epidemiol. Community Health. 58:114-115.
3. Sibai, B.M., et al. 1997. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am. J. Obstet. Gynecol. 177:1003-1010.
4. Goldenberg, R.L., Hauth, J.C., and Andrews, W.W. 2000. Intraucerine infection and preterm delivery. N. Engl. J. Med. 342:1500-1507.
5. Kunath, T., Strumpf, D., and Rossant, J. 2004. Early trophoblast determination and stem cell maintenance in the mouse - a review. Placenta. 25(Suppl.):S32-S38.
6. Johnson, M.H., and Ziomek, C.A. 1981. The foundation of two distinct cell lineages within the mouse morula. Cell. 24:71-80.
7. Rossant, J., and Vijh, K.M. 1980. Ability of outside cells from preimplantation mouse embryos to form inner cell mass derivatives. Dev. Biol. 76:475-482.
8. Larue, L, Ohsugi, M., Hirchenhain J., and Kemler, R. 1994. E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc. Natl. Acad. Sci. U. S. A. 91:8263-8267.
9. Bloom, T.L. 1989. The effects of phorbol ester on mouse blastomeres: a role for protein kinase C in compaction? Development. 106:159-171.
10. Chambers, I., et al. 2003. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 113:643-655.
11. Mitsui, K., et al. 2003. The homeoprotein Nanog is required for maintenance of pluripocency in mouse epiblast and ES cells. Cell. 113:631-642.
12. Nichols, J., et al. 1998. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 95:379-391.
13. Liu, L., and Roberts, R.M. 1996. Silencing of the gene for the beta subunit of human chorionic gonadotropin by the embryonic transcription factor Oct-3/4. J. Biol. Chem. 271:16683-16689.
14. Ezashi, T., Ghosh, D., and Roberts, R.M. 2001. Repression of Ets-2-induced transactivation of the tau interferon promoter by Oct-4. Mol. Cell. Biol. 21:7883-7891.
15. Avilion, A.A., et al. 2003. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17:126-140.
16. Hay, D.C., Sutherland, L., Clark, J., and Burdon, T. 2004. Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells. 22:225-235.
17. Norwitz, E.R., Schust, D.J., and Fisher, S.J. 2001. Implantation and the survival of early pregnancy. N. Engl. J. Med. 345:1400-1408.
18. Paria, B.C., Reese, J., Das, S.K., and Dey, S.K. 2002. Deciphering the cross-talk of implantation: advances and challenges. Science. 296:218S-2188.
19. Conneely, O.M., Mulac-Jericevic, B., DeMayo, F., Lydon, J.P., and O'Malley, B.W. 2002. Reproductive functions of progesterone receptors. Recent Prog. Horm. Res. 57:339-355.
20. Hewitt, S.C., and Korach, K.S. 2002. Estrogen receptors: structure, mechanisms and function. Rev. Endocr. Metab. Disord. 3:193-200.
21. Paria, B.C., Tan, J., Lubahn, D.B., Dey, S.K., and Das, S.K. 1999. Uterine decidual response occurs in estrogen receptor-alpha-deficient mice. Endocrinology. 140:2704-2710.
22. Curtis Hewitt, S., Goulding, E.H., Eddy, E.M., and Korach, K.S. 2002. Studies using the estrogen receptor alpha knockout uterus demonstrate that implantation but not decidualization-associated signaling is estrogen dependent. Biol. Reprod. 67:1268-1277.
23. Ma, W.G., Song, H., Das, S.K., Paria, B.C., and Dey, S.K. 2003. Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation. Proc. Natl. Acad. Sci. U. S. A. 100:2963-2968.
24. Paria, B.C., et al. 1998. Coordination of differential effects of primary estrogen and catecholestrogen on two distinct targets mediates embryo implantation in the mouse. Endocrinology. 139:5235-5246.
25. Stewart, C.L., et al. 1992. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature. 359:76-79.
26. Robb, L., et al. 1998. Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat. Med. 4:303-308.
27. Crossey, P.A., Pillai, C.C., and Miell, J.P. 2002. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J. Clin. Invest. 110:411-418. doi:10.1172/JC1200210077.
28. Benson, G.V., et al. 1996. Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development. 122:2687-2696.
29. Taylor, H.S., Arici, A., Olive, D., and Igarashi, P 1998. HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. J. Clin. Invest. 101:1379-1384.
30. Christian, M., et al. 2002. Cyclic AMP-induced forkhead transcription factor, FKHR, cooperates with CCAAT/enhancer-binding protein beta in differentiating human endometrial stromal cells. J. Biol. Chem. 277:20825-20832.
31. Paria, B.C., Elenius, K., Klagsbrun, M., and Dey, S.K. 1999. Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: a possible role for heparin sulfate proteoglycans and ErbB4 in blastocyst implantation. Development. 126:1997-2005.
32. Wang, H., et al. 2003. Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation. Proc. Natl. Acad. Sci. U. S. A. 100:14914-14919.
33. Fazleabas, A.T., Donnelly, K.M., Srinivasan, S., Fortman, J.D., and Miller, J.B. 1999. Modulation of the baboon (Papio anubis) uterine endometrium by chorionic gonadotrophin during the period of uterine receptivity. Proc. Natl. Acad. Sci. U. S. A. 96:2543-2548.
34. Hemberger, M., et al. 2001. UniGene cDNA array-based monitoring of transcriptorne changes during mouse placental development. Proc. Natl. Acad. Sci. U. S. A. 98:13126-13131.
35. Reese, J., et al. 2001. Global gene expression analysis to identify molecular markers of uterine receptivity and embryo implantation. J. Biol. Chem. 276:44137-44145.
36. Kao, L.C., et al. 2002. Global gene profiling in human endometrium during the window of implantation. Endocrinology. 143:2119-2138.
37. Carson, D.D., et al. 2002. Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol. Hum. Reprod. 8:871-879.
38. Lim, H., et al. 1997. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell. 91:197-208.
39. Wang, H., et al. 2004. Rescue of female infertility from the loss of cyclooxygenase-2 by compensatory up-regulation of cydooxygenase-1 is a function of generic makeup. J. Biol. Chem. 279:10649-10658.
40. Cheng, J.G., and Srewart, C.L. 2003. Loss of cyclooxygenase-2 retards decidual growth bur does not inhibit embryo implantation or development to term. Biol. Reprod. 68:401-404.
41. Reese, J., Brown, N., Paria, B.C., Morrow, J., and Dey, S.K. 1999. COX-2 compensation in the uterus of COX-1 deficient mice during the pre-implantation period. Mol. Cell Endocrinol. 150:23-31.
42. Lim, H., et al. 1999. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev. 13:1561-1574.
43. Barak, Y., et al. 2002. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc. Natl. Acad. Sci. U. S. A. 99:303-308.
44. Paria, B.C., et al. 2001. Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors. Proc. Natl. Acad. Sci. U. S. A. 98:1047-1052.
45. Matsumoto, H., Zhao, X., Das, S.K., Hogan, B.L., and Dey, S.K. 2002. Indian hedgehog as a progesterone-responsive factor mediating epithelial-mesenchymal interactions in the mouse uterus. Dev. Biol. 245:280-290.
46. Daikoku, T., et al. 2004. Uterine Msx-1 and Wnt4 signaling becomes aberrant in mice with the loss of leukemia inhibitory factor or Hoxa-10: Evidence for a novel cytokine-homeobox-Wnt signaling in implantation. Mol. Endocrinol. 18:1238-1250.
47. Genbacev, O.D., et al. 2003. Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface. Science. 299:405-408.
48. Rosen, S.D. 2004. Ligands for L-selectin: homing, inflammation, and beyond. Annu. Rev. Immunol. 22:129-156.
49. Carson, D.D., et al. 2000. Embryo implantation. Dev. Biol. 223:217-237.
50. Damsky, C.H., Fitzgerald, M.L., and Fisher, S.J. 1992. Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J. Clin. Invest. 89:210-222.
51. Zhou, Y., et al. 1997. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J. Clin. Invest. 99:2139-2151.
52. Guleria, I., and Pollard, J.W. 2000. The trophoblast is a component of the innate immune system during pregnancy. Nat. Med. 6:589-593.
53. Red-Horse, K., Drake, P.M., Gunn, M.D., and Fisher, S.J. 2001. Chemokine ligand and receptor expression in the pregnant uterus: reciprocal patterns in complementary cell subsets suggest functional roles. Am. J. Pathol. 159:2199-2213.
54. Song, H., et al. 2002. Cytosolic phospholipase A2alpha is crucial for 'on-time' embryo implantation that directs subsequent development. Development. 129:2879-2889.
55. Herz, J., Couthier, D.E., and Hammer, R.E. 1993. Correction: LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell 73:428.
56. Wilcox, A.J., Baird, D.D., and Weinberg, C.R. 1999. Time of implantation of the conceptus and loss of pregnancy. N. Engl. J. Med. 340:1796-1799.
57. Tanaka, S., Kunath, T., Hadjantonakis, A.K., Nagy, A., and Rossant, J. 1998. Promotion of trophoblast stem cell proliferation by FGF4. Science. 282:2072-2075.
58. Rossant, J., and Cross, J.C 2001. Placental development: lessons from mouse mutants. Nat. Rev. Genet. 2:538-548.
59. Xu, R.H., et al. 2002. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat. Biotechnol. 20:1261-1264.
60. Cross, J.C., Werb, Z., and Fisher, S.J. 1994. Implantation and the placenta: key pieces of the development puzzle. Science. 266:1508-1518.
61. Nagy, A., et al. 1990. Embryonic stem cells alone are able to support fetal development in the mouse. Development. 110:815-821.
62. Nagy, A., Rossanr, J., Nagy, R., Abramow-Newerly, W., and Roder, J.C. 1993. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 90:8424-8428.
63. Cross, J.C., et al. 2003. Genes, development and evolution of the placenta. Placenta. 24:123-130.
64. Russ, A.P., et al. 2000. Eomesodermin is required for mouse trophoblast development and mesoderm formation. Nature. 404:95-99.
65. Auman, H.J., et al. 2002. Transcription factor AP-2gamma is essential in the extra-embryonic lineages for early postimplantation development. Development. 129:2733-2747.
66. Luo, J., et al. 1997. Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-beta. Nature. 388:778-782.
67. Adamson, S.L., et al. 2002. Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev. Biol. 250:358-373.
68. Ma, G.T., et al. 2001. Nodal regulates trophoblast differentiation and placental development. Dev. Biol. 236:124-135.
69. Guillemot, F., Nagy, A., Auerbach, A., Rossant, J., and Joyner, A.L. 1994. Essential role of Mash-2 in extraembryonic development. Nature. 371:333-336.
70. Wang, J., Mager, J., Schnedier, E., and Magnuson, T. 2002. The mouse PcG gene eed is required for Hox gene repression and extraembryonic development. Mamm. Genome. 13:493-503.
71. Janatpour, M.J., et al. 1999. A repertoire of differentially expressed transcription factors that offers insight in to mechanisms of human cytotrophoblast differentiation. Dev. Genet. 25:146-157.
72. Janatpour, M.J., et al. 2000. Id-2 regulates critical aspects of human cytotrophoblast differentiation, invasion and migration. Development. 127:549-558.
73. Riley, P., Anson-Cartwright, L., and Cross, J.C. 1998. The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis. Nat. Genet. 18:271-275.
74. Firulli, A.B., McFadden, D.G., Lin, Q., Srivastava, D., and Olson, B.N. 1998. Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1. Nat. Genet. 18:266-270.
75. Knofler, M., Meinhardt, G., Vasicek, R., Husslein, P., and Egarter, C. 1998. Molecular cloning of the human Hand1 gene/cDNA and its tissue-restricted expression in cytotrophoblastic cells and heart. Gene. 224:77-86.
76. Jones, B. W., Fetter, R.D., Tear, G., and Goodman, C.S. 1995. glial cells missing: a genetic switch that controls glial versus neuronal fate. Cell. 82:1013-1023.
77. Anson-Cartwright, L., et al. 2000. The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat. Genet. 25:311-314.
78. Sapin, V., Dolle, P., Hindelang, C., Kastner, P., and Chambon, P. 1997. Defects of the chorioallantoic placenta in mouse RXRalpha null fetuses. Dev. Biol. 191:29-41.
79. Wendling, O., Chambon, P., and Mark, M. 1999. Retinoid X receptors are essential for early mouse development and placentogenesis. Proc. Natl. Acad. Sci. U. S. A. 96:547-551.
80. Barak, Y., et al. 1999. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell. 4:585-595.
81. Monkley, S.J., Delaney, S.J., Pennisi, D.J., Chrisriansen, J.H., and Wainwright, B.J. 1996. Targeted disruption of the Wnt2 gene results in placentation defects. Development. 122:3343-3353.
82. Schmidr, C., et al. 1995. Scarrer factor/hepatocyte growrh factor is essential for liver development. Nature. 373:699-702.
83. Yamamoto, H., et al. 1998. Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev. 12:1315-1326.
84. Kenner, L., et al. 2004. Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. J. Cell Biol. 164:613-623.
85. Hatano, N., et al. 2003. Essential role for ERK2 mitogen-activared protein kinase in placental development. Genes Cells. 8:847-856.
86. Dietrich, S., et al. 1999. The role of SF/HGF and c-Met in the development of skeletal muscle. Development. 126:1621-1629.
87. Takahashi, Y., et al. 2003. SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. EMBO J. 22:372-384.
88. Isermann, B., Hendrickson, S.B., Hutley, K., Wing, M., and Weiler, H. 2001. Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulin-deficient mice from early lethality and reveals a secondary developmental block. Development. 128:827-838.
89. Gallicano, G.I., Bauer, C., and Fuchs, E. 2001. Rescuing desmoplakin function in extra-embryonic ectoderm reveals the importance of this protein in embryonic heart, neuroepithelium, skin and vasculature. Development. 128:929-941.
90. Mishina, Y., Crombie, R., Bradley, A., and Behringer, R.R. 1999. Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis. Dev. Biol. 213:314-326.
91. Sugimoto, M., Karashima, Y., Abe, K., Tan, S.S., and Takagi, N. 2003. Tetraploid embryos rescue the early defects of tw5/tw5 mouse embryos. Genesis. 37:162-171.
92. Goto, Y., and Takagi, N. 1998. Tetraploid embryos rescue embryonic lethality caused by an additional maternally inherited X chromosome in the mouse. Development. 125:3353-3363.
93. Jaquemar, D., et al. 2003. Keratin 8 protection of placental barrier function. J. Cell Biol. 161:749-756.
94. Bajoria, R., Sooranna, S.R., Ward, S., D'Souza, S., and Hancock, M. 2001. Placental transport rather than maternal concentration of amino acids regulates fetal growth in monochorionic twins: implications for fetal origin hypothesis. Am. J. Obstet. Gynecol. 185:1239-1246.
95. Genbacev, O., Bass, K.E., Joslin, R.J., and Fisher, S.J. 1995. Maternal smoking inhibits early human cytotrophoblast differentiation. Reprod. Toxicol. 9:245-255.
96. Genbacev, O., et al. 2000. Concordant in situ and in vitro data show that maternal cigarette smoking negatively regulates placental cytotrophoblast passage through the cell cycle. Reprod. Toxicol. 14:495-506.
97. Pereira, L., Maidji, E., McDonagh, S., Genbacev, O., and Fisher, S. 2003. Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity. J. Virol. 77:13301-13314.
98. Yamamoto-Tabata, T., McDonagh, S., Chang, H.T., Fisher, S., and Pereira, L. 2004. Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J. Virol. 78:2831-2840.
99. Wright, A., et al. 2004. Trisomy 21 is associated with variable defects in cytotrophoblast differentiation along the invasive pathway. Am. J. Med. Genet. In press.
100. Maltepe, E., and Simon, M.C. 1998. Oxygen, genes, and development: an analysis of the role of hypoxic gene regulation during murine vascular development. J. Mol. Med. 76:391-401.
101. Jauniaux, E., et al. 2000. Onset of maternal arterial blood flow and piacental oxidative stress. A possible factor in human early pregnancy failure. Am. J. Pathol. 157:2111-2122.
102. Jauniaux, E., Gulbis, B., and Burton, G.J. 2003. The human first trimester gestational sac limits rather than facilitates oxygen transfer to the foetus - a review. Placenta. 24(Suppl. A):S86-S93.
103. Genbacev, O., Joslin, R., Damsky, C.H., Polliotti, B.M., and Fisher, S.J. 1996. Hypoxia alters early gestation human cytotrophoblast differentiation/ invasion in vitro and models the placental defects that occur in preeclampsia. J. Clin. Invest. 97:540-550.
104. Genbacev, O., Zhou, Y., Ludlow, J.W., and Fisher, S.J. 1997. Regulation of human placental development by oxygen tension. Science. 277:1669-1672.
105. Adelman, D.M., Gertsenstein, M., Nagy, A., Simon, M.C., and Maltepe, E. 2000. Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev. 14:3191-3203.
106. Douglas, R.M., and Haddad, G.G. 2003. Genetic models in applied physiology: invited review: effect of oxygen deprivation on cell cycle activity: a profile of delay and arrest. J. Appl. Physiol. 94:2068-2083; discussion 2084.
107. Semenza, G.L. 2003. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer. 3:721-732.
108. Safran, M., and Kaelin, W.G., Jr. 2003. HIF hydroxylation and the mammalian oxygen-sensing pathway. J. Clin. Invest. 111:779-783. doi:10.1172/JCI200318181.
109. Masson, N., and Ratcliffe, P.J. 2003. HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels. J. Cell. Sci. 116:3041-3049.
110. Wykoff, C.C., Pugh, C.W., Maxwell, P.H., Harris, A.L., and Ratcliffe, P.J. 2000. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene. 19:6297-6305.
111. Gnarra, J.R., et al. 1997. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 94:9102-9107.
112. Katschinski, D.M., et al. 2002. Heat induction of the unphosphorylated form of hypoxia-inducible factor-1alpha is dependent on heat shock protein-90 activity. J. Biol. Chem. 277:9262-9267.
113. Voss, A.K., Thomas, T., and Gruss, P. 2000. Mice lacking HSP90beta fail to develop a placental labyrinth. Development. 127:1-11.
114. Genbacev, O., Krtolica, A., Kaelin, W., and Fisher, S.J. 2001. Human cytotrophoblast expression of the von Hippel-Lindau protein is downregulated during uterine invasion in situ and upregulated by hypoxia in vitro. Dev. Biol. 233:526-536.
115. Pugh, C.W., and Ratcliffe, P.J. 2003. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9:677-684.
116. Zhou, Y., et al. 2002. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am. J. Pathol. 160:1405-1423.
117. Makinen, T., and Alitalo, K. 2002. Molecular mechanisms of lymphangiogenesis. Cola Spring Harb. Symp. Quant. Biol. 67:189-196.
118. Zhou, Y., Bellingard, V., Feng, K.T., McMaster, M., and Fisher, S.J. 2003. Human cytotrophoblasts promote endothelial survival and vascular remodeling through secretion of Ang2, PlGF, and VEGF-C. Dev. Biol. 263:114-125.
119. Gale, N.W., et al. 2002. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev. Cell. 3:411-423.
120. Damsky, C.H., and Fisher, S.J. 1998. Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors. Curr. Opin. Cell Biol. 10:660-666.
121. Lain, K.Y., and Roberts, J.M. 2002. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA. 287:3183-3186.
122. Zhou, Y., Damsky, C.H., and Fisher, S.J. 1997. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J. Clin. Invest. 99:2152-2164.
123. Maynard, S.E., et al. 2003. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111:649-658. doi:10.1172/ JCI200317189.
124. Levine, R.J., et al. 2004. Circulating angiogenic factors and ehe risk of preeclampsia. N. Engl. J. Med. 350:672-683.
125. Thadhani, R., et al. 2004. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J. Clin. Endocrinol. Metab. 89:770-775.